Anbarasu Kumaraswamy

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4”.

Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4

Neoplasia(2020)10.1016/j.neo.2020.04.002

N/A

0DataRank · unranked

29 citations

David A. Sampson, Archana Sehrawat, Anbarasu Kumaraswamy, Duanchen Sun, Yuzhuo Wang +12 more

PROX1 is an early driver of lineage plasticity in prostate cancer

Journal of Clinical Investigation(2025)10.1172/jci187490

N/A

0DataRank · unranked

9 citations

Mingchen Shi, Anbarasu Kumaraswamy, Dong Lin, Dhruv Khokhani, Yong Wang +41 more

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer

npj Precision Oncology(2025)10.1038/s41698-025-01002-8

N/A

0DataRank · unranked

1 citations

Ya‐Mei Hu, Joel A. Yates, Chao Zhang, Eva S. Rodansky, Dhruv Khokhani +26 more

LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer

Neoplasia(2025)10.1016/j.neo.2025.101151

N/A

0DataRank · unranked

1 citations

Rahul Mannan, Olivia A Swaim, Eva S. Rodansky, Xiaoming Wang, Aaron M. Udager +10 more